SARM1 activation promotes axonal degeneration via a two-step phase transition
- 22 August 2025
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 435-445
Abstract
SARM1 is a key executioner of axonal degeneration, acting through NAD⁺ depletion by NADase activity of its TIR domain. Although normally autoinhibited, SARM1 becomes activated in response to axonal damage; however, the underlying mechanism remains unclear. Here, using a class of pyridine-containing compounds that trigger SARM1-dependent axon degeneration, we uncover a two-step activation process. First, NMN primes the base exchange activity of SARM1, generating covalent adducts between ADP-ribose (an NAD⁺ hydrolysis product) and the compounds. These ADP-ribose conjugates then serve as molecular glues to promote the assembly of superhelical SARM1 filaments, in which TIR domains adopt an active configuration. After reaching solubility limits, these filaments condense into stable, phase-separated assemblies with full enzymatic activity. Unexpectedly, several clinical-stage SARM1 inhibitors targeting its TIR domain also form such adducts, paradoxically promoting its activation. These findings reveal a molecular mechanism that spatially restricts SARM1 activation to damaged axons and offer new guidance for therapeutic strategies targeting SARM1.Keywords
Funding Information
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
- Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
This publication has 59 references indexed in Scilit:
- SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolitesiScience, 2022
- SARM1 signaling mechanisms in the injured nervous systemCurrent Opinion in Neurobiology, 2021
- Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to DegenerateCell Reports, 2021
- 1,6-Hexanediol, commonly used to dissolve liquid–liquid phase separated condensates, directly impairs kinase and phosphatase activitiesJournal of Biological Chemistry, 2021
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1Cell Reports, 2020
- cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axonsExperimental Neurology, 2020
- A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell DeathiScience, 2019
- TIR Domain Proteins Are an Ancient Family of NAD+-Consuming EnzymesCurrent Biology, 2018
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004